drugset / Trial / NCT04694755

Treatment of CRF With Syndrome Differentiation of TCM

NCT04694755 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

Taking the patients with chronic respiratory failure caused by COPD as the research object and the acute exacerbation of COPD as the main outcome index, the investigators hope to establish the syndrome differentiation and treatment scheme of COPD treated by traditional Chinese medicine, reduce the acute exacerbation of AECOPD, improve the clinical symptoms, improve the quality of life, reduce the mortality, preliminarily explore the mechanism of action, and lay the foundation for further research.

Timeline

Start
2021-01
Primary completion
2022-05
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Subject invigorating heart and lung formula Unknown — Oral
Subject invigorating kidney and protecting lung formula Unknown — Oral

Indications